Specific T cells for the treatment of cytomegalovirus and/or adenovirus in the context of hematopoietic stem cell transplantation

Publication date: Available online 30 April 2016
Source:Journal of Allergy and Clinical Immunology
Author(s): Rita Creidy, Despina Moshous, Fabien Touzot, Caroline Elie, Bénédicte Neven, Aurélie Gabrion, Marianne-Leruez Ville, Sébastien Maury, Brigitte Ternaux, Jennifer Nisoy, Jean-Marc Luby, Sébastien Héritier, Jean-Hugues Dalle, Marie Ouachée-Chardin, Aliénor Xhaard, Xavier Thomas, Patrice Chevallier, Laetitia Souchet, Jean-Marc Treluyer, Capucine Picard, Salima Hacein-Bey-Abina, Liliane Dal Cortivo, Stéphane Blanche, Marina Cavazzana

Teaser

We report the results of a clinical trial designed to investigate the safety and efficacy of CMV and adenovirus specific T-cells in pediatric or adult presenting with viral infections after allogeneic hematopoietic stem cell transplantation.


from #ENT via xlomafota13 on Inoreader http://ift.tt/1SDG6qH
via IFTTT